Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tilda Research is a private healthcare technology company focused on improving clinical trial operations for sponsors, CROs, and research sites. Rather than developing therapeutic assets, the company provides an AI-native workflow platform and "AI teammates" that automate operational work across study startup, monitoring, compliance, recruitment, data management, and site finances. Tilda also operates or supports a network of U.S. clinical research sites and positions its technology as a way to reduce trial timelines, lower administrative burden, and improve data quality. The company appears to be commercially active, venture backed, and oriented toward phase I-IV trial execution across multiple therapeutic areas rather than a single drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tilda Research.